Literature DB >> 8060256

Electromotive administration of a new morphine formulation: morphine citrate.

R Stephen1, D Miotti, R Bettaglio, C Rossi, C Bonezzi.   

Abstract

Two formulations of morphine citrate were synthesized: trimorphine citrate, 3(MH)+(C6H5O7)3- and morphine sodium citrate, 3(MH)+3Na+2(C6H5O7)3-. Four healthy individuals volunteered to undergo electromotive administration of the two formulations. Application of electric current (2 mA) to solutions of trimorphine citrate for 1 h resulted in iontophoretic transcutaneous administration of therapeutic quantities of morphine, without deleterious reduction in the pH of the drug solutions. Application of a 2-mA current to solutions of morphine sodium citrate for 2 h resulted in combined iontophoretic and electrophoretic delivery of morphine with increased administration rates and an improved buffering capacity of the drug solutions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060256     DOI: 10.1111/j.1525-1594.1994.tb02233.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  4 in total

Review 1.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

2.  Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis.

Authors:  A Rosamilia; P L Dwyer; J Gibson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

3.  Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer.

Authors:  Savino Mauro Di Stasi; Claus Riedl
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

4.  Acute postoperative pain management: focus on iontophoretic transdermal fentanyl.

Authors:  Consalvo Mattia; Flaminia Coluzzi
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.